Atul Khullar, MD, MSc
- 3Articles
- 42.8KReads1
- 2016–2020Active
- 11Collaborators
- 62Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Atul Khullar, MD, MSc, has published research focused on treatment approaches for major depressive disorder (MDD), including the use of sublingual ketamine to improve treatment accessibility. The work also addresses functional recovery in MDD with an emphasis on early optimized treatment strategies. Khullar's publications appeared between 2016 and 2020 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
